Phase 2 Clinical Trial Begins for Sudan Ebolavirus Vaccine Candidate — Precision Vaccinations News

  Health Trends, Health Trends - UK

(Precision Vaccinations News)

The Sabin Vaccine Institute recently announced the launch of a Phase 2 clinical trial for its vaccine against Sudan ebolavirus at Makerere University Walter Reed Project (MUWRP) in Uganda.

This is a vital development as there are currently no approved vaccines…



Source link